Home›People›Michael Chobotov
MC

Michael Chobotov

Director, Provisio Medical Technologies Corp

DirectorRoles at 2 startups
Updated Nov 7, 2026·Latest SEC filing Oct 22, 2026·Suggest an edit

About Michael Chobotov

Michael Chobotov, Ph.D., has been a director of Provisio Medical Technologies Corp since 2022. Provisio is a commercial-stage medical device company in San Diego. Its SLT IVUS System and Support Crossing Catheter are FDA 510(k) cleared. The company is also building deep-learning guidance for peripheral artery disease on the same hardware.

Earlier, Chobotov was chief technology officer of Endologix, Inc.

Experience

This experience comes from official bios and from SEC filings. For roles taken from filings, the years are when the filings name Michael Chobotov in the role, so the role may have started earlier or lasted longer.

Provisio Medical Technologies Corp Current
Director
2022 – Present · San Diego, CA
San Diego company that makes an FDA-cleared catheter system and is building real-time blood flow and AI guidance tools for peripheral artery disease treatment.
Provisio Medical, Inc.
Director
2022 – 2025 · San Diego, CA
Endologix, Inc.
chief technology officer

Key Colleagues at Startups

The people Michael Chobotov works with at each company, as listed on that company's latest Form D.

Provisio Medical Technologies Corp · Form D, Oct 22, 2026
SR
Stephen Ryan
President & Chief Executive Officer, director
JM
John McCallum
Chairman of the Board
CC
Christopher Carcerano
Vice President & Chief Development Officer
Provisio Medical, Inc. · Form D, May 1, 2025
JM
SR
Stephen Ryan
President and director

Sources

  1. SECProvisio Medical Technologies Corp Form D, filed Oct 22, 2026
  2. SECProvisio Medical, Inc. Form D, filed May 1, 2025
  3. company siteAbout Provisio